[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f_MiMUP0L7AWySwtABdqgNrK6L1DIJNDTuxk_HspPs9c":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":84,"rows":91},"Washington State University",[4],81,false,23,0,46745,15,64,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Alcohol Use Disorder",6,{"name":18,"count":19},"Interaction",4,{"name":21,"count":19},"Alcohol Use Disorder (AUD)",{"name":23,"count":24},"Hypertension",3,{"name":26,"count":24},"Diabetes",{"name":28,"count":24},"Interaction Drug Food",{"name":30,"count":24},"Family Members",{"name":32,"count":24},"Opioid Use Disorder",[34,39,44,49,54,59,64,69,74,79],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05846451","Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints","2025-05-01","Oxycodone",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06692933","Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel","2025-08-31","Cannabidiol in the form of hemp",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06693960","Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach","2025-09-15","Drug cocktail",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT05924022","Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering","2025-09-30","Hyperbaric Oxygen Treatment Full",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06053411","Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac","2025-12-18","Diclofenac",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT05134857","The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study","2026-08-31","Zonisamide",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT06323837","Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment","2026-09-01","Mirtazapine",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT07393672","Effects of Hemp-Derived Cannabinoids on Menopause Symptoms","2026-11-10","Hemp-derived cannabinoids",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT07296874","Acute Effects of Cannabis on Cognition and Affect","2028-05","THC 20mg",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT07494084","Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","2029-03","Metyrapone And Hydrocortisone",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,121,139,157,179,200,222,242,266,284,302,323,344,365,383,403,428,453,477,495,521,539,566,584,602,620,647,665,683,701],{"intervention":83,"totalTrials":93,"cells":94},1,{"EARLY_PHASE1":95,"PHASE1":97,"PHASE2":99,"PHASE3":101,"PHASE4":103,"NA":119},{"trials":96,"activeCount":9},[],{"trials":98,"activeCount":9},[],{"trials":100,"activeCount":9},[],{"trials":102,"activeCount":9},[],{"trials":104,"activeCount":93,"soonestReadout":82},[105],{"nctId":80,"briefTitle":81,"status":106,"phases":107,"primaryCompletion":82,"completion":108,"start":109,"enrollment":110,"conditions":111,"interventions":116},"NOT_YET_RECRUITING",[89],"2029-07","2026-07-01",48,[112,113,114,115],"Shift Work Schedule","Circadian Rhythm","Insulin Resistance","Circadian Misalignment",[83,117,118],"Dextrose","insulin",{"trials":120,"activeCount":9},[],{"intervention":117,"totalTrials":93,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":137},{"trials":124,"activeCount":9},[],{"trials":126,"activeCount":9},[],{"trials":128,"activeCount":9},[],{"trials":130,"activeCount":9},[],{"trials":132,"activeCount":93,"soonestReadout":82},[133],{"nctId":80,"briefTitle":81,"status":106,"phases":134,"primaryCompletion":82,"completion":108,"start":109,"enrollment":110,"conditions":135,"interventions":136},[89],[112,113,114,115],[83,117,118],{"trials":138,"activeCount":9},[],{"intervention":118,"totalTrials":93,"cells":140},{"EARLY_PHASE1":141,"PHASE1":143,"PHASE2":145,"PHASE3":147,"PHASE4":149,"NA":155},{"trials":142,"activeCount":9},[],{"trials":144,"activeCount":9},[],{"trials":146,"activeCount":9},[],{"trials":148,"activeCount":9},[],{"trials":150,"activeCount":93,"soonestReadout":82},[151],{"nctId":80,"briefTitle":81,"status":106,"phases":152,"primaryCompletion":82,"completion":108,"start":109,"enrollment":110,"conditions":153,"interventions":154},[89],[112,113,114,115],[83,117,118],{"trials":156,"activeCount":9},[],{"intervention":68,"totalTrials":93,"cells":158},{"EARLY_PHASE1":159,"PHASE1":161,"PHASE2":163,"PHASE3":173,"PHASE4":175,"NA":177},{"trials":160,"activeCount":9},[],{"trials":162,"activeCount":9},[],{"trials":164,"activeCount":93,"soonestReadout":67},[165],{"nctId":65,"briefTitle":66,"status":166,"phases":167,"primaryCompletion":67,"completion":67,"start":168,"enrollment":169,"conditions":170,"interventions":172},"RECRUITING",[87],"2024-06-17",60,[171],"Stimulant Use Disorder",[68],{"trials":174,"activeCount":9},[],{"trials":176,"activeCount":9},[],{"trials":178,"activeCount":9},[],{"intervention":78,"totalTrials":93,"cells":180},{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":194,"PHASE4":196,"NA":198},{"trials":182,"activeCount":9},[],{"trials":184,"activeCount":9},[],{"trials":186,"activeCount":93,"soonestReadout":77},[187],{"nctId":75,"briefTitle":76,"status":106,"phases":188,"primaryCompletion":77,"completion":77,"start":189,"enrollment":190,"conditions":191,"interventions":193},[87],"2026-07",90,[192],"Cannabis Use",[78],{"trials":195,"activeCount":9},[],{"trials":197,"activeCount":9},[],{"trials":199,"activeCount":9},[],{"intervention":73,"totalTrials":93,"cells":201},{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":216,"PHASE4":218,"NA":220},{"trials":203,"activeCount":9},[],{"trials":205,"activeCount":9},[],{"trials":207,"activeCount":93,"soonestReadout":72},[208],{"nctId":70,"briefTitle":71,"status":166,"phases":209,"primaryCompletion":72,"completion":72,"start":210,"enrollment":211,"conditions":212,"interventions":215},[87],"2026-02-11",104,[213,214],"Menopause","Perimenopause",[73],{"trials":217,"activeCount":9},[],{"trials":219,"activeCount":9},[],{"trials":221,"activeCount":9},[],{"intervention":63,"totalTrials":93,"cells":223},{"EARLY_PHASE1":224,"PHASE1":226,"PHASE2":228,"PHASE3":236,"PHASE4":238,"NA":240},{"trials":225,"activeCount":9},[],{"trials":227,"activeCount":9},[],{"trials":229,"activeCount":93,"soonestReadout":62},[230],{"nctId":60,"briefTitle":61,"status":166,"phases":231,"primaryCompletion":62,"completion":62,"start":232,"enrollment":233,"conditions":234,"interventions":235},[87],"2022-01-07",205,[21],[63],{"trials":237,"activeCount":9},[],{"trials":239,"activeCount":9},[],{"trials":241,"activeCount":9},[],{"intervention":53,"totalTrials":93,"cells":243},{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":258,"PHASE3":260,"PHASE4":262,"NA":264},{"trials":245,"activeCount":9},[],{"trials":247,"activeCount":93,"soonestReadout":52},[248],{"nctId":50,"briefTitle":51,"status":249,"phases":250,"primaryCompletion":52,"completion":251,"start":252,"enrollment":253,"conditions":254,"interventions":255},"ACTIVE_NOT_RECRUITING",[86],"2025-12-30","2023-12-04",36,[32],[53,256,257],"Hyperbaric Oxygen Treatment Sham","Hyperbaric Oxygen Treatment Partial Pressure",{"trials":259,"activeCount":9},[],{"trials":261,"activeCount":9},[],{"trials":263,"activeCount":9},[],{"trials":265,"activeCount":9},[],{"intervention":256,"totalTrials":93,"cells":267},{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":276,"PHASE3":278,"PHASE4":280,"NA":282},{"trials":269,"activeCount":9},[],{"trials":271,"activeCount":93,"soonestReadout":52},[272],{"nctId":50,"briefTitle":51,"status":249,"phases":273,"primaryCompletion":52,"completion":251,"start":252,"enrollment":253,"conditions":274,"interventions":275},[86],[32],[53,256,257],{"trials":277,"activeCount":9},[],{"trials":279,"activeCount":9},[],{"trials":281,"activeCount":9},[],{"trials":283,"activeCount":9},[],{"intervention":257,"totalTrials":93,"cells":285},{"EARLY_PHASE1":286,"PHASE1":288,"PHASE2":294,"PHASE3":296,"PHASE4":298,"NA":300},{"trials":287,"activeCount":9},[],{"trials":289,"activeCount":93,"soonestReadout":52},[290],{"nctId":50,"briefTitle":51,"status":249,"phases":291,"primaryCompletion":52,"completion":251,"start":252,"enrollment":253,"conditions":292,"interventions":293},[86],[32],[53,256,257],{"trials":295,"activeCount":9},[],{"trials":297,"activeCount":9},[],{"trials":299,"activeCount":9},[],{"trials":301,"activeCount":9},[],{"intervention":48,"totalTrials":93,"cells":303},{"EARLY_PHASE1":304,"PHASE1":313,"PHASE2":315,"PHASE3":317,"PHASE4":319,"NA":321},{"trials":305,"activeCount":93,"soonestReadout":47},[306],{"nctId":45,"briefTitle":46,"status":166,"phases":307,"primaryCompletion":47,"completion":308,"start":309,"enrollment":310,"conditions":311,"interventions":312},[85],"2025-12-31","2024-09-26",16,[18],[48],{"trials":314,"activeCount":9},[],{"trials":316,"activeCount":9},[],{"trials":318,"activeCount":9},[],{"trials":320,"activeCount":9},[],{"trials":322,"activeCount":9},[],{"intervention":58,"totalTrials":93,"cells":324},{"EARLY_PHASE1":325,"PHASE1":334,"PHASE2":336,"PHASE3":338,"PHASE4":340,"NA":342},{"trials":326,"activeCount":93,"soonestReadout":57},[327],{"nctId":55,"briefTitle":56,"status":166,"phases":328,"primaryCompletion":57,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":333},[85],"2026-08-18","2024-03-01",30,[18],[58],{"trials":335,"activeCount":9},[],{"trials":337,"activeCount":9},[],{"trials":339,"activeCount":9},[],{"trials":341,"activeCount":9},[],{"trials":343,"activeCount":9},[],{"intervention":43,"totalTrials":93,"cells":345},{"EARLY_PHASE1":346,"PHASE1":355,"PHASE2":357,"PHASE3":359,"PHASE4":361,"NA":363},{"trials":347,"activeCount":93,"soonestReadout":42},[348],{"nctId":40,"briefTitle":41,"status":166,"phases":349,"primaryCompletion":42,"completion":308,"start":350,"enrollment":351,"conditions":352,"interventions":353},[85],"2024-06-20",24,[18],[43,354],"Clopidogrel",{"trials":356,"activeCount":9},[],{"trials":358,"activeCount":9},[],{"trials":360,"activeCount":9},[],{"trials":362,"activeCount":9},[],{"trials":364,"activeCount":9},[],{"intervention":354,"totalTrials":93,"cells":366},{"EARLY_PHASE1":367,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":379,"NA":381},{"trials":368,"activeCount":93,"soonestReadout":42},[369],{"nctId":40,"briefTitle":41,"status":166,"phases":370,"primaryCompletion":42,"completion":308,"start":350,"enrollment":351,"conditions":371,"interventions":372},[85],[18],[43,354],{"trials":374,"activeCount":9},[],{"trials":376,"activeCount":9},[],{"trials":378,"activeCount":9},[],{"trials":380,"activeCount":9},[],{"trials":382,"activeCount":9},[],{"intervention":38,"totalTrials":93,"cells":384},{"EARLY_PHASE1":385,"PHASE1":393,"PHASE2":395,"PHASE3":397,"PHASE4":399,"NA":401},{"trials":386,"activeCount":93,"soonestReadout":37},[387],{"nctId":35,"briefTitle":36,"status":166,"phases":388,"primaryCompletion":37,"completion":37,"start":389,"enrollment":310,"conditions":390,"interventions":392},[85],"2023-06-01",[391],"Herbal Interaction",[38],{"trials":394,"activeCount":9},[],{"trials":396,"activeCount":9},[],{"trials":398,"activeCount":9},[],{"trials":400,"activeCount":9},[],{"trials":402,"activeCount":9},[],{"intervention":404,"totalTrials":93,"cells":405},"Cannabis",{"EARLY_PHASE1":406,"PHASE1":408,"PHASE2":410,"PHASE3":422,"PHASE4":424,"NA":426},{"trials":407,"activeCount":9},[],{"trials":409,"activeCount":9},[],{"trials":411,"activeCount":9},[412],{"nctId":413,"briefTitle":414,"status":415,"phases":416,"primaryCompletion":417,"completion":417,"start":418,"enrollment":419,"conditions":420,"interventions":421},"NCT05488509","Acute Effects of Cannabis on Everyday Life Memory","COMPLETED",[87],"2025-05-17","2023-08-21",121,[192],[404],{"trials":423,"activeCount":9},[],{"trials":425,"activeCount":9},[],{"trials":427,"activeCount":9},[],{"intervention":429,"totalTrials":93,"cells":430},"Cannabigerol",{"EARLY_PHASE1":431,"PHASE1":433,"PHASE2":445,"PHASE3":447,"PHASE4":449,"NA":451},{"trials":432,"activeCount":9},[],{"trials":434,"activeCount":9},[435],{"nctId":436,"briefTitle":437,"status":415,"phases":438,"primaryCompletion":439,"completion":439,"start":440,"enrollment":441,"conditions":442,"interventions":444},"NCT05257044","Acute Effects of Cannabigerol",[86],"2023-11-28","2022-03-24",38,[443],"Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition",[429],{"trials":446,"activeCount":9},[],{"trials":448,"activeCount":9},[],{"trials":450,"activeCount":9},[],{"trials":452,"activeCount":9},[],{"intervention":454,"totalTrials":93,"cells":455},"Midazolam HCl",{"EARLY_PHASE1":456,"PHASE1":467,"PHASE2":469,"PHASE3":471,"PHASE4":473,"NA":475},{"trials":457,"activeCount":9},[458],{"nctId":459,"briefTitle":460,"status":415,"phases":461,"primaryCompletion":462,"completion":462,"start":463,"enrollment":11,"conditions":464,"interventions":465},"NCT04392011","Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural Product",[85],"2021-08-31","2019-10-09",[28],[454,466],"Dextromethorphan HBr",{"trials":468,"activeCount":9},[],{"trials":470,"activeCount":9},[],{"trials":472,"activeCount":9},[],{"trials":474,"activeCount":9},[],{"trials":476,"activeCount":9},[],{"intervention":466,"totalTrials":93,"cells":478},{"EARLY_PHASE1":479,"PHASE1":485,"PHASE2":487,"PHASE3":489,"PHASE4":491,"NA":493},{"trials":480,"activeCount":9},[481],{"nctId":459,"briefTitle":460,"status":415,"phases":482,"primaryCompletion":462,"completion":462,"start":463,"enrollment":11,"conditions":483,"interventions":484},[85],[28],[454,466],{"trials":486,"activeCount":9},[],{"trials":488,"activeCount":9},[],{"trials":490,"activeCount":9},[],{"trials":492,"activeCount":9},[],{"trials":494,"activeCount":9},[],{"intervention":496,"totalTrials":93,"cells":497},"Nicotine gum",{"EARLY_PHASE1":498,"PHASE1":511,"PHASE2":513,"PHASE3":515,"PHASE4":517,"NA":519},{"trials":499,"activeCount":9},[500],{"nctId":501,"briefTitle":502,"status":503,"phases":504,"primaryCompletion":505,"completion":506,"start":507,"enrollment":310,"conditions":508,"interventions":509},"NCT05157672","Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon","UNKNOWN",[85],"2023-08-31","2024-08-31","2021-12-14",[28],[496,510],"Letrozole",{"trials":512,"activeCount":9},[],{"trials":514,"activeCount":9},[],{"trials":516,"activeCount":9},[],{"trials":518,"activeCount":9},[],{"trials":520,"activeCount":9},[],{"intervention":510,"totalTrials":93,"cells":522},{"EARLY_PHASE1":523,"PHASE1":529,"PHASE2":531,"PHASE3":533,"PHASE4":535,"NA":537},{"trials":524,"activeCount":9},[525],{"nctId":501,"briefTitle":502,"status":503,"phases":526,"primaryCompletion":505,"completion":506,"start":507,"enrollment":310,"conditions":527,"interventions":528},[85],[28],[496,510],{"trials":530,"activeCount":9},[],{"trials":532,"activeCount":9},[],{"trials":534,"activeCount":9},[],{"trials":536,"activeCount":9},[],{"trials":538,"activeCount":9},[],{"intervention":540,"totalTrials":93,"cells":541},"Metformin",{"EARLY_PHASE1":542,"PHASE1":556,"PHASE2":558,"PHASE3":560,"PHASE4":562,"NA":564},{"trials":543,"activeCount":9},[544],{"nctId":545,"briefTitle":546,"status":415,"phases":547,"primaryCompletion":548,"completion":549,"start":550,"enrollment":310,"conditions":551,"interventions":552},"NCT03772262","Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach",[85],"2018-11-30","2019-03-31","2018-04-05",[28],[540,553,554,555],"Furosemide","Midazolam oral solution","Rosuvastatin Oral",{"trials":557,"activeCount":9},[],{"trials":559,"activeCount":9},[],{"trials":561,"activeCount":9},[],{"trials":563,"activeCount":9},[],{"trials":565,"activeCount":9},[],{"intervention":553,"totalTrials":93,"cells":567},{"EARLY_PHASE1":568,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":580,"NA":582},{"trials":569,"activeCount":9},[570],{"nctId":545,"briefTitle":546,"status":415,"phases":571,"primaryCompletion":548,"completion":549,"start":550,"enrollment":310,"conditions":572,"interventions":573},[85],[28],[540,553,554,555],{"trials":575,"activeCount":9},[],{"trials":577,"activeCount":9},[],{"trials":579,"activeCount":9},[],{"trials":581,"activeCount":9},[],{"trials":583,"activeCount":9},[],{"intervention":554,"totalTrials":93,"cells":585},{"EARLY_PHASE1":586,"PHASE1":592,"PHASE2":594,"PHASE3":596,"PHASE4":598,"NA":600},{"trials":587,"activeCount":9},[588],{"nctId":545,"briefTitle":546,"status":415,"phases":589,"primaryCompletion":548,"completion":549,"start":550,"enrollment":310,"conditions":590,"interventions":591},[85],[28],[540,553,554,555],{"trials":593,"activeCount":9},[],{"trials":595,"activeCount":9},[],{"trials":597,"activeCount":9},[],{"trials":599,"activeCount":9},[],{"trials":601,"activeCount":9},[],{"intervention":555,"totalTrials":93,"cells":603},{"EARLY_PHASE1":604,"PHASE1":610,"PHASE2":612,"PHASE3":614,"PHASE4":616,"NA":618},{"trials":605,"activeCount":9},[606],{"nctId":545,"briefTitle":546,"status":415,"phases":607,"primaryCompletion":548,"completion":549,"start":550,"enrollment":310,"conditions":608,"interventions":609},[85],[28],[540,553,554,555],{"trials":611,"activeCount":9},[],{"trials":613,"activeCount":9},[],{"trials":615,"activeCount":9},[],{"trials":617,"activeCount":9},[],{"trials":619,"activeCount":9},[],{"intervention":621,"totalTrials":93,"cells":622},"MetFORMIN Oral Solution",{"EARLY_PHASE1":623,"PHASE1":637,"PHASE2":639,"PHASE3":641,"PHASE4":643,"NA":645},{"trials":624,"activeCount":9},[625],{"nctId":626,"briefTitle":627,"status":415,"phases":628,"primaryCompletion":629,"completion":629,"start":630,"enrollment":310,"conditions":631,"interventions":633},"NCT05365451","Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters",[85],"2023-07-22","2022-04-11",[18,632],"Endogenous Biomarkers",[621,634,635,636],"Cimetidine 400 MG","Furosemide Oral Liquid Product","Probenecid 500 MG",{"trials":638,"activeCount":9},[],{"trials":640,"activeCount":9},[],{"trials":642,"activeCount":9},[],{"trials":644,"activeCount":9},[],{"trials":646,"activeCount":9},[],{"intervention":634,"totalTrials":93,"cells":648},{"EARLY_PHASE1":649,"PHASE1":655,"PHASE2":657,"PHASE3":659,"PHASE4":661,"NA":663},{"trials":650,"activeCount":9},[651],{"nctId":626,"briefTitle":627,"status":415,"phases":652,"primaryCompletion":629,"completion":629,"start":630,"enrollment":310,"conditions":653,"interventions":654},[85],[18,632],[621,634,635,636],{"trials":656,"activeCount":9},[],{"trials":658,"activeCount":9},[],{"trials":660,"activeCount":9},[],{"trials":662,"activeCount":9},[],{"trials":664,"activeCount":9},[],{"intervention":635,"totalTrials":93,"cells":666},{"EARLY_PHASE1":667,"PHASE1":673,"PHASE2":675,"PHASE3":677,"PHASE4":679,"NA":681},{"trials":668,"activeCount":9},[669],{"nctId":626,"briefTitle":627,"status":415,"phases":670,"primaryCompletion":629,"completion":629,"start":630,"enrollment":310,"conditions":671,"interventions":672},[85],[18,632],[621,634,635,636],{"trials":674,"activeCount":9},[],{"trials":676,"activeCount":9},[],{"trials":678,"activeCount":9},[],{"trials":680,"activeCount":9},[],{"trials":682,"activeCount":9},[],{"intervention":636,"totalTrials":93,"cells":684},{"EARLY_PHASE1":685,"PHASE1":691,"PHASE2":693,"PHASE3":695,"PHASE4":697,"NA":699},{"trials":686,"activeCount":9},[687],{"nctId":626,"briefTitle":627,"status":415,"phases":688,"primaryCompletion":629,"completion":629,"start":630,"enrollment":310,"conditions":689,"interventions":690},[85],[18,632],[621,634,635,636],{"trials":692,"activeCount":9},[],{"trials":694,"activeCount":9},[],{"trials":696,"activeCount":9},[],{"trials":698,"activeCount":9},[],{"trials":700,"activeCount":9},[],{"intervention":702,"totalTrials":93,"cells":703},"Midazolam Hcl 1Mg\u002FMl Inj",{"EARLY_PHASE1":704,"PHASE1":717,"PHASE2":719,"PHASE3":721,"PHASE4":723,"NA":725},{"trials":705,"activeCount":9},[706],{"nctId":707,"briefTitle":708,"status":415,"phases":709,"primaryCompletion":710,"completion":505,"start":711,"enrollment":712,"conditions":713,"interventions":716},"NCT05081583","Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients",[85],"2023-01-16","2021-09-16",22,[714,715],"Interaction, Adverse Herb-Drug","Diabetes Mellitus, Type 2",[702],{"trials":718,"activeCount":9},[],{"trials":720,"activeCount":9},[],{"trials":722,"activeCount":9},[],{"trials":724,"activeCount":9},[],{"trials":726,"activeCount":9},[]]